Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Hydroxyurea × 1 year × Clear all

Phase

Phase 2 8 Phase 1 6 Phase 4 1 Phase 3 1 Phase 1/2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Polycythemia Vera 1

Interventions

Dexamethasone 14 Fluorouracil 9 Saline Solution 8 Carboplatin 8 Bupivacaine 8 Bevacizumab 8 Tobacco Use Cessation Devices 7 Nivolumab 7 Lenalidomide 7 pembrolizumab 6 anlotinib 6 Specimen Handling 6 Rituximab 6 Prednisone 6 Magnetic Resonance Spectroscopy 6 Letrozole 6 Human Papillomavirus Recombinant Vaccine nonavalent 6 Cisplatin 6 Standard of Care 5 Propofol 5 trametinib 4 lenvatinib 4 ibrutinib 4 dabrafenib 4 cabozantinib 4 Trastuzumab 4 Tamoxifen 4 Surveys and Questionnaires 4 Sodium Chloride 4 Ropivacaine 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05853458 2026-04-07

HU-F-AIM

Novartis

Phase 4 Terminated

Polycythemia Vera

Data powered by HemOnc (CC BY 4.0) Colophon ⚡